Determinants and outcomes of bloodstream infections related to obesity

• Published in: European journal of clinical microbiology & infectious diseases 2022-11, Vol.41 (11), p.1347-1353
• Main Authors: Edwards, Felicity, Glen, Kate, Harris, Patrick N. A., Paterson, David L., Laupland, Kevin B.
• Format: Article
• Language: English
• Subjects: Biomedical and Life Sciences; Biomedicine; Comorbidity; Confidence intervals; E coli; Epidemiology; Fatalities; Health care; Infections; Infectious diseases; Internal Medicine; Medical Microbiology; Microbiology; Morbidity; Obesity; Original; Original Article; Patients; Populations; Public health; Regression models; Soft tissues; Statistical analysis
• ISSN: 0934-9723; 1435-4373
• DOI: 10.1007/s10096-022-04501-9

Although obesity is a major healthcare problem that is increasing in many populations worldwide, there are limited studies that have examined its contribution to infectious diseases morbidity and mortality. The aim of this study was to examine the clinical determinants and outcomes of bloodstream infections among patients with obesity. All adults within the publicly funded healthcare system in Queensland, Australia, identified with a BSI during 2017–2019 were included and the presence of obesity was based on discharge International Classification of Diseases (ICD-10) codes. Clinical features, microbiology, and outcomes were compared among obese and non-obese subjects. A total of 24,602 incident BSI were identified among 21,613 Queensland residents; of which 4,579 (21.2%) and 17,034 (78.8%) were classified as obese or non-obese, respectively. Obese patients were less likely to have community associated infections and were more likely to be younger, female, have higher comorbidity scores, and have bone and joint or soft tissue infections as compared to non-obese subjects. Obese patients had a lower proportion of Escherichia coli BSI and higher proportions of b-haemolytic streptococci. Although obese patients had longer hospital admissions and more repeat incident BSI within 1 year, they had lower overall case fatality. In a logistic regression model, obesity was associated with a lower risk for 30-day case fatality (adjusted odds ratio 0.51, 95% confidence interval 0.45–0.58). Obesity is associated with significant differences in the determinants and outcome of BSI. Increasing rates of obesity is likely to influence the epidemiology of BSI in populations.